Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 3.49% | $2.63M | $635.44B | 36.39% | 74 Outperform | |
| Johnson & Johnson | 2.80% | $2.11M | $590.40B | 52.13% | 78 Outperform | |
| Micron | 2.62% | $1.97M | $473.78B | 333.20% | 79 Outperform | |
| Bank of America | 2.01% | $1.52M | $384.86B | 17.76% | 72 Outperform | |
| Merck & Company | 1.71% | $1.29M | $301.96B | 36.16% | 80 Outperform | |
| Chevron | 1.56% | $1.18M | $370.23B | 17.75% | 71 Outperform | |
| UnitedHealth | 1.46% | $1.10M | $261.06B | -37.84% | 72 Outperform | |
| AbbVie | 1.45% | $1.10M | $404.24B | 11.02% | 66 Neutral | |
| Wells Fargo | 1.36% | $1.02M | $273.88B | 12.99% | 80 Outperform | |
| Citigroup | 1.19% | $897.01K | $208.04B | 45.07% | 68 Neutral |